Christopher J. Sonnenday, MD, MHS
- Assistant Professor, Surgery
- Assistant Professor, Health Management and Policy
Christopher Sonnenday, MD, MHS, is an Assistant Professor in the Department of Surgery,
Division of Transplant Surgery at the University of Michigan Health System in Ann
Arbor, Michigan. He is also an Assistant Professor in the Department of Health Management
and Policy at the University of Michigan School Of Public Health.
Dr. Sonnenday received his medical degree from Vanderbilt University, Nashville, Tennessee, in 1997, and went on to complete his General Surgery residency at the Johns Hopkins University, Baltimore, Maryland, in June of 2005. While a research fellow in transplantation from 2000 to 2003, he completed a Masters of Health Sciences in Clinical Investigation at the Bloomberg School of Public Health in 2003.
After completion of his residency, Dr. Sonnenday continued on at Johns Hopkins as a Fellow in Surgical Oncology and Instructor of Surgery until he joined the faculty of the Section of General Surgery at the University of Michigan Health System in July of 2006. He completed a fellowship in abdominal transplant surgery in June of 2008. Dr. Sonnenday's clinical interests focus on hepatobiliary and pancreatic surgery, and transplantation of the liver, kidney, and pancreas.
- Fellow, Transplantation, The University of Michigan, Department of Surgery, 2006 - 2008
- Fellow, Surgical Oncology, The Johns Hopkins University School of Medicine, 2005 - 2006
- MHS, The Bloomberg School of Public Health, 2002 - 2004
- PhD, Medicine, Vanderbilt University School of Medicine, 1993 - 1997
His research interests include investigation of the patterns of utilization and outcomes of hepatobiliary surgery and liver transplantation, geographic and racial disparities in the utilization of and access to solid organ transplantation, variation in the care of GI cancers, and the multidisciplinary treatment of hepatobiliary malignancies.
Sonnenday, C.J., and Simeone, D.M. (2008). "Criminal" profiling of the pancreas: when is aggressive therapy indicated for a non-aggressive entity? Ann Surg 580-582.
Englesbe, M.J., Ads, Y.M., Cohn, J.A., Sonnenday, C.J., Lynch, R., Sung, R.S., Pelletier, S.J., Birkmeyer, J.D., and Punch, J.D. (2008). The effects of donor and recipient practices on transplant center finances Am J Transplant 586-592.
Englesbe, M.J., Dimick, J.B., Sonnenday, C.J., Share, D.A., and Campbell, D.A. Jr. (2007). The Michigan Surgical Quality Collaborative: Will a Statewide Quality Improvement Initiative Pay for Itself? Ann Surg 1100-1103.
Sonnenday, C.J., Dimick, J.B., Schulick, R.S., and Choti, M.A. (2007). Racial and Geographic Disparities in the Utilization of Surgical Therapy for Hepatocellular Cancer. J Gastrointest Surg 1636-46.
Sonnenday, C.J., Warren, D.S., Cooke, S.K., Dietz, H., and Montgomery, R.A. (2004). A novel chimeric ribozyme vector produces potent inhibition of ICAM-1 expression on ischemic vascular endothelium. J Gene Med 1394-1402.
Sonnenday, C.J., Warren, D.S., Cooper, M., Saminiego, M., Haas, M., King, K.E., Shirey, R.S., and Montgomery, R.A. (2004). Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy Am J Transplant 1315-1322.